← Evidence map

ArticleYonago acta medica2020

Erratum for Ikeda et al., "Pemafibrate Dramatically Ameliorated the Values of Liver Function Tests and Fibrosis Marker in Patients with Non-Alcoholic Fatty Liver Disease".

Suguru Ikeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Erratum for Ikeda et al., "Pemafibrate Dramatically Ameliorated the Values of Liver Function Tests and Fibrosis Marker in Patients with Non-Alcoholic Fatty Liver Disease". | OpenQuestion